XML 39 R9.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 29, 2020
Mar. 31, 2019
Operating activities    
Net income (loss) before attribution to noncontrolling interests $ 8,993 $ (1,598)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Current period provision for expected credit losses 768 (50)
Depreciation and amortization 12,295 11,749
Deferred income taxes 1,185 (1,309)
Preferred stock option mark-to-market adjustment   5,914
Stock-based compensation expense 3,950 3,731
Other 234 838
Changes in operating assets and liabilities:    
Accounts receivable (1,839) (3,443)
Income tax receivable 932 10,715
Inventories (2,281) 810
Prepaid expenses 6,118 7,888
Other current assets (532) (13,855)
Other assets and liabilities 2,670 (3,258)
Accounts payable 4,604 8,108
Income and other taxes payable 568 746
Accrued expenses and other current liabilities (1,903) (11,003)
Deferred revenue (2,028) (2,170)
Net cash provided by operating activities 33,734 13,813
Investing activities    
Purchases of property and equipment (5,933) (8,658)
Loans issued (7,413) (859)
Repayments of loans issued 3,790 925
Other 1 329
Net cash used in investing activities (9,555) (8,263)
Financing activities    
Proceeds from issuance of preferred stock   252,530
Repayments of term loan (5,000) (5,000)
Net proceeds (repayments) of revolving credit facility 640 (240,026)
Dividends paid to common stockholders (7,237) (7,125)
Dividends paid to preferred stockholders (3,412) (2,040)
Issuance costs associated with preferred stock   (7,179)
Tax payments for equity award issuances (1,383) (869)
Proceeds from exercise of stock options 1,241 51
Distributions to noncontrolling interest holders (30) (19)
Other (350) 50
Net cash used in financing activities (15,531) (9,627)
Effect of exchange rate changes on cash and cash equivalents (183) 92
Change in cash and cash equivalents 8,465 (3,985)
Cash and cash equivalents at beginning of period 27,911 33,258
Cash and cash equivalents at end of period $ 36,376 $ 29,273